Sep 012024
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Lazcluze | lazertinib | 8/19/2024 | To treat non-small cell lung cancer | Drug Trials Snapshot | |
| Niktimvo | axatilimab-csfr | 8/14/2024 | To treat chronic graft-versus-host disease (cGVHD) | Drug Trials Snapshot | |
| Livdelzi | seladelpar | 8/14/2024 | To treat primary biliary cholangitis (PBC) | Drug Trials Snapshot | |
| Nemluvio | nemolizumab-ilto | 8/12/2024 | To treat prurigo nodularis | Drug Trials Snapshot | |
| Yorvipath | palopegteriparatide | 8/9/2024 | To treat hypoparathyroidism | Drug Trials Snapshot | |
| Voranigo | vorasidenib | 8/6/2024 | To treat Grade 2 astrocytoma or oligodendroglioma | Drug Trials Snapshot |
Sorry, the comment form is closed at this time.